Letrozole vs anastrozole for height augmentation in short pubertal males: First year data

30Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Design: Patients are seen for laboratory evaluation and physical examination every 6 months, bone age yearly, DEXA and spine film every 2 years. They will be followed until they reach their final height. This is a preliminary report after 1 year of treatment. Setting: A single academic children's hospital outpatient clinic. Patients: Boys with age >10 years, bone age ≤14 years, clinical and hormonal evidence of central puberty, and either height

Cite

CITATION STYLE

APA

Neely, E. K., Kumar, R. B., Payne, S. L., Ranadive, S. A., & Suchet, D. I. (2014). Letrozole vs anastrozole for height augmentation in short pubertal males: First year data. Journal of Clinical Endocrinology and Metabolism, 99(11), 4086–4093. https://doi.org/10.1210/jc.2014-2432

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free